P
MEDP icon

Pitcairn’s Medpace MEDP Stock Holding History

Pitcairn’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-850
Closed -$437K – 339
2025
Q3 		$437K Sell
850
-1,282
-60% -$560K 0.03% 385
2025
Q2 		$669K Sell
2,132
-252
-11% -$75.7K 0.04% 337
2025
Q1 		$726K Sell
2,384
-9
-0.4% -$3.03K 0.04% 333
2024
Q4 		$795K Sell
2,393
-43
-2% -$14.6K 0.05% 301
2024
Q3 		$813K Sell
2,436
-342
-12% -$130K 0.05% 305
2024
Q2 		$1.14M Buy
2,778
+67
+2% +$26.5K 0.07% 249
2024
Q1 		$1.1M Sell
2,711
-233
-8% -$81.9K 0.07% 254
2023
Q4 		$902K Sell
2,944
-91
-3% -$24.6K 0.07% 258
2023
Q3 		$735K Sell
3,035
-462
-13% -$118K 0.06% 268
2023
Q2 		$840K Sell
3,497
-95
-3% -$19.7K 0.07% 237
2023
Q1 		$675K Sell
3,592
-590
-14% -$122K 0.06% 274
2022
Q4 		$888K Sell
4,182
-238
-5% -$47.5K 0.09% 197
2022
Q3 		$695K Buy
4,420
+65
+1% +$10.4K 0.08% 229
2022
Q2 		$652K Buy
4,355
+250
+6% +$36.2K 0.07% 242
2022
Q1 		$672K Sell
4,105
-89
-2% -$14.7K 0.06% 279
2021
Q4 		$913K Sell
4,194
-1,377
-25% -$288K 0.06% 227
2021
Q3 		$1.05M Sell
5,571
-24
-0.4% -$4.38K 0.07% 193
2021
Q2 		$988K Sell
5,595
-205
-4% -$35.4K 0.07% 205
2021
Q1 		$951K Sell
5,800
-1,613
-22% -$247K 0.07% 202
2020
Q4 		$1.03M Sell
7,413
-23
-0.3% -$2.9K 0.08% 171
2020
Q3 		$831K Buy
7,436
+273
+4% +$31.6K 0.07% 178
2020
Q2 		$666K Sell
7,163
-555
-7% -$47.2K 0.06% 189
2020
Q1 		$566K Buy
7,718
+3,894
+102% +$338K 0.07% 183
2019
Q4 		$321K Buy
3,824
+1,004
+36% +$77.7K 0.03% 372
2019
Q3 		$237K Buy
+2,820
New +$213K 0.02% 467

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pitcairn's MEDP Position: Q4 2025 in Review

Pitcairn sold out of Medpace (MEDP) in Q4 2025, closing a stake of 850 shares — an estimated $437K sold.

Pitcairn first reported a position in MEDP in Q3 2019 and held it in 25 quarters. The position peaked at $1.14M in Q2 2024. 785 funds tracked by Wall St. Rank hold MEDP as of Q4 2025.

  • Pitcairn reported no remaining Medpace position as of Q4 2025 after selling out during the quarter.
  • Pitcairn sold 850 Medpace shares in Q4 2025, an estimated $437K.
  • Pitcairn first reported a position in Medpace in Q3 2019 and held it in 25 quarters.
  • Pitcairn's Medpace position peaked at $1.14M in Q2 2024.
  • 785 funds tracked by Wall St. Rank held Medpace as of Q4 2025.

Based on Pitcairn's 13F filing for Q4 2025.